KIDS
Orthopediatrics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About KIDS
Orthopediatrics Corp.
An orthopedic company focused exclusively on advancing the field of pediatric orthopedics
Healthcare Equipment and Supplies
08/31/2006
10/12/2017
NASDAQ Stock Exchange
562
12-31
Common stock
2850 Frontier Drive, Warsaw, Indiana 46582
--
Orthopediatrics Corp., originally organized as an Indiana limited liability company on August 31, 2006, was transformed into a Delaware corporation on November 30, 2007. The company is the only global medical device company focused on providing comprehensive trauma and deformity correction, scoliosis and sports medicine products to the pediatric orthopedic market to improve the lives of children with orthopedic diseases. The company designs, develops and commercializes innovative orthopedic implants, instruments and specialty stents to meet the needs of pediatric surgeons or orthotics and their patients, who the company believes are largely ignored by the orthopedic industry.
Earnings Call
Company Financials
EPS
KIDS has released its 2025 Q3 earnings. EPS was reported at -0.24, versus the expected -0.26, beating expectations. The chart below visualizes how KIDS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
KIDS has released its 2025 Q3 earnings report, with revenue of 61.25M, reflecting a YoY change of 12.23%, and net profit of -11.77M, showing a YoY change of -48.67%. The Sankey diagram below clearly presents KIDS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


